Bristol-Myers Squibb Live Stock Price Today, Share Analysis and Chart

Name: Bristol-Myers Squibb Co.: Is Infosys Ltd. worth buying?
Item: Bristol-Myers Squibb Co.
Rating: 2.719333375
Author: Trendlyne DVM scores

Mid-range Performer

about

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

55.26 -1.36 (-2.40%)

29.96% Gain from 52W Low

13.7M

XNYS Volume

XNYS 16 Jan, 2026 4:30 PM (EST)

Medium Financial Strength

50.0 / 100

Affordable Valuation

57.7 / 100

Technically Neutral

59.9 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target upside is 3%

23 analysts

Bristol-Myers Squibb Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bristol-Myers Squibb Live Stock Price Today, Share Analysis and Chart

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

29.96% Gain from 52W Low

SWOT Analysis

Bristol-Myers Squibb Live Price Chart